Windtree Therapeutics Inc’s recent filing unveils that its President and CEO Fraser Craig acquired Company’s shares for reported $4942.0 on Oct 08 ’24. In the deal valued at $0.91 per share,5,431 shares were bought. As a result of this transaction, Fraser Craig now holds 8,638 shares worth roughly $2159.5.
Ladenburg Thalmann initiated its Windtree Therapeutics Inc [WINT] rating to a Buy in a research note published on June 26, 2020; the price target was $12.25.
Price Performance Review of WINT
On Monday, Windtree Therapeutics Inc [NASDAQ:WINT] saw its stock fall -0.90% to $0.25. Over the last five days, the stock has lost -20.62%. Windtree Therapeutics Inc shares have fallen nearly -27.60% since the year began. Nevertheless, the stocks have fallen -97.84% over the past one year. While a 52-week high of $14.75 was reached on 01/02/25, a 52-week low of $0.25 was recorded on 01/13/25. SMA at 50 days reached $0.4518, while 200 days put it at $3.6888.
Levels Of Support And Resistance For WINT Stock
The 24-hour chart illustrates a support level at 0.2433, which if violated will result in even more drops to 0.2336. On the upside, there is a resistance level at 0.2593. A further resistance level may holdings at 0.2656. The Relative Strength Index (RSI) on the 14-day chart is 27.17, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0471, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.69%. Stochastics %K at 5.91% indicates the stock is a buying.
How much short interest is there in Windtree Therapeutics Inc?
A steep rise in short interest was recorded in Windtree Therapeutics Inc stocks on 2024-11-15, dropping by 17833.0 shares to a total of 30861.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 48694.0 shares. There was a decline of -57.78%, which implies that there is a negative sentiment for the stock.
